Skip to main content
. 2017 Mar 28;2017(3):CD011343. doi: 10.1002/14651858.CD011343.pub2

NCT02943460.

Trial name or title NCT02943460.
Methods Randomised, double‐blind, placebo‐controlled trial.
Participants Patients with primary sclerosing cholangitis.
Interventions GS‐9674 vs placebo.
Outcomes Adverse events.
Starting date November 2016.
Contact information GS‐US‐428‐4025@Gilead.com
Notes